Insider Trading & Ownership of Karen N. Prange

Location
Fort Lauderdale, FL
Summary
The estimated net worth of Karen N. Prange is at least $1,687,612 dollars as of 22 May 2026. Karen N. Prange is the Director of Embecta Corp. and owns shares of Embecta Corp. (EMBC) stock worth about $824.1K. Karen N. Prange is the Director of AtriCure, Inc. and owns shares of AtriCure, Inc. (ATRC) stock worth about $755.6K. Karen N. Prange is the Director of Outset Medical, Inc. and owns shares of Outset Medical, Inc. (OM) stock worth about $69.3K. Karen N. Prange is the Director of ViewRay, Inc. and owns shares of ViewRay, Inc. stock worth about $38.7K.
Signature
/s/ Karen N. Prange
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Karen N. Prange and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Karen N. Prange has 6 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,687,612.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Embecta Corp. ($824,056).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Karen N. Prange

EMBC Forms 3/4/5

Embecta Corp.

Relationship
Director
Holdings value
$824,056
Past year net change
Change %
Report period
11 Feb 2026
ATRC Forms 3/4/5

AtriCure, Inc.

Relationship
Director
Holdings value
$755,586
Past year net change
-$85,950
Change %
-10%
Report period
20 May 2026
VRAYQ Forms 3/4/5

ViewRay, Inc.

Relationship
Director
Holdings value
$38,716
Past year net change
Change %
Report period
19 Jul 2023
NVRO Forms 3/4/5

NEVRO CORP

Relationship
Director
Holdings value
$0
Past year net change
Change %
Report period
03 Apr 2025

Insider Transactions Reported by Karen N. Prange:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .